MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy

by Annelisa M. Cornel, Iris L. Mimpen, Stefan Nierkens
Published 2020-07-01

Monitoring Immune Responses in Neuroblastoma Patients during Therapy

by Celina L. Szanto, Annelisa M. Cornel, Saskia V. Vijver, Stefan Nierkens
Published 2020-02-01

Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies

by Annelisa M. Cornel, Niek P. van Til, Jaap Jan Boelens, Jaap Jan Boelens, Jaap Jan Boelens, Stefan Nierkens
Published 2018-05-01

Efficient lentiviral transduction method to gene modify cord blood CD8+ T cells for cancer therapy applications

by Vania Lo Presti, Annelisa M. Cornel, Maud Plantinga, Ester Dünnebach, Jurgen Kuball, Jaap Jan Boelens, Stefan Nierkens, Niek P. van Til
Published 2021-06-01

αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression

by Josephine G. M. Strijker, Ronja Pscheid, Esther Drent, Jessica J. F. van der Hoek, Bianca Koopmans, Kimberley Ober, Sander R. van Hooff, Waleed M. Kholosy, Annelisa M. Cornel, Chris Coomans, Andrea Bisso, Marleen M. van Loenen, Jan J. Molenaar, Judith Wienke
Published 2021-09-01

Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma

by Celina L. Szanto, Annelisa M. Cornel, Sara M. Tamminga, Eveline M. Delemarre, Coco C. H. de Koning, Denise A. M. H. van den Beemt, Ester Dunnebach, Michelle L. Tas, Miranda P. Dierselhuis, Lieve G. A. M. Tytgat, Max M. van Noesel, Kathelijne C. J. M. Kraal, Jaap-Jan Boelens, Alwin D. R. Huitema, Stefan Nierkens
Published 2021-04-01